GB201018149D0 - Method of treatment - Google Patents

Method of treatment

Info

Publication number
GB201018149D0
GB201018149D0 GBGB1018149.3A GB201018149A GB201018149D0 GB 201018149 D0 GB201018149 D0 GB 201018149D0 GB 201018149 A GB201018149 A GB 201018149A GB 201018149 D0 GB201018149 D0 GB 201018149D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1018149.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB1018149.3A priority Critical patent/GB201018149D0/en
Publication of GB201018149D0 publication Critical patent/GB201018149D0/en
Priority to PCT/EP2011/068674 priority patent/WO2012055879A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
GBGB1018149.3A 2010-10-27 2010-10-27 Method of treatment Ceased GB201018149D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1018149.3A GB201018149D0 (en) 2010-10-27 2010-10-27 Method of treatment
PCT/EP2011/068674 WO2012055879A1 (en) 2010-10-27 2011-10-25 Method of treatment by inhibition of baz1b

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1018149.3A GB201018149D0 (en) 2010-10-27 2010-10-27 Method of treatment

Publications (1)

Publication Number Publication Date
GB201018149D0 true GB201018149D0 (en) 2010-12-08

Family

ID=43365602

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1018149.3A Ceased GB201018149D0 (en) 2010-10-27 2010-10-27 Method of treatment

Country Status (2)

Country Link
GB (1) GB201018149D0 (en)
WO (1) WO2012055879A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2971129B1 (en) * 2013-03-15 2018-05-09 Sutter Bay Hospitals Falz for use as a target for therapies to treat cancer
CN110628898B (en) * 2019-10-23 2022-02-22 中国医学科学院北京协和医院 BAZ1B susceptibility SNP locus detection reagent and kit prepared by same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110081362A1 (en) * 2008-01-31 2011-04-07 The Brigham And Women's Hospital, Inc. Treatment of cancer
WO2010033667A2 (en) * 2008-09-17 2010-03-25 The Rockefeller University Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity
GB0919432D0 (en) * 2009-11-05 2009-12-23 Glaxosmithkline Llc Use

Also Published As

Publication number Publication date
WO2012055879A1 (en) 2012-05-03

Similar Documents

Publication Publication Date Title
EP2773754A4 (en) Method of treatment
GB201110095D0 (en) Method of treatment
ZA201304280B (en) Treatment of jak2-mediated conditions
EP2723384A4 (en) Treatment of proteinopathies
EP2611496A4 (en) Treatment methods
EP2717855A4 (en) Methods of treatment
GB201018147D0 (en) Method of treatment
HUE063599T2 (en) Methods of treatment or reduction of edematous-fibrosclerotic panniculopathy
IL220594A0 (en) Treatment method
IL256026B (en) Methods of treatment
GB201003920D0 (en) Method of treatment
EP2536421A4 (en) Method for treatment of psoriasis
GB201020045D0 (en) Method for the treatment of biogas
EP2585103A4 (en) Method of treatment
GB201018149D0 (en) Method of treatment
GB201020015D0 (en) Method of treatment
EP2791324A4 (en) Method of treatment
EP2440238A4 (en) Methods of treatment
GB201005071D0 (en) Method of treatment
GB201003917D0 (en) Method of treatment
GB201000318D0 (en) Method of treatment
EP2532254A4 (en) Method for treatment of lacto-n-biose-containing solution
GB201111530D0 (en) Method of treatment
GB201109509D0 (en) Method of treatment
GB201109266D0 (en) Method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)